AF December 14, 2023 ANNOUNCEMENT: BostonGene’s Identification of Elevated CCNG1 Levels in Multiple Cancer Types Unlocks Potential of Tumor-Targeted Gene Therapy AF December 14, 2023 Sarcoma Oncology Center Leverages BostonGene’s AI-driven Molecular and Immune Profiling Platform to Identify Novel Treatment Options for Patients with Advanced Cancers
